Cycrin combined with Premphase 14/14

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2001 66 Female 145 lb 12/23/2005 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2004 56 Female 12/23/2005 United States
Primary
Secondary
Optic Ischaemic Neuropathy Other Serious 8/8/2002 57 Female 2/2/2006 United States
Primary
Secondary
Thrombosis Other Serious 8/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 12/1/2003 59 Female 162 lb 6/9/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/8/2002 57 Female 192 lb 11/16/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2000 Female 1/12/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2004 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/20/1998 Female 12/22/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/13/1998 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/3/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2001 66 Female 145 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2005 Female 12/22/2006 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 1/1/1997 56 Female 140 lb 6/5/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 9/25/1998 Female 10/29/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/6/1998 Female 10/29/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2000 Female 10/12/2007 United States
Primary
Secondary
Systemic Lupus Erythematosus Other Serious 4/1/2000 Female 11/13/2007 Consumer United States
Primary
Secondary
Vomiting Other Serious 1/1/1997 54 Female 127 lb 12/3/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 2/21/2001 Female 12/11/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/28/2003 47 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 12/16/2002 61 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2006 Female 2/11/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/7/2002 Female 5/8/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/7/2002 Female 5/8/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 12/1/2003 Female 162 lb 6/4/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Death Female 6/25/2008 United States
Primary
Secondary
Vomiting Other Serious 1/1/1997 Female 127 lb 7/15/2008 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Death Female 7/16/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/21/2008 Lawyer United States
Primary
Secondary
Vomiting Other Serious 1/1/1997 Female 127 lb 7/29/2008 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/24/2002 61 Female 10/9/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/21/2004 69 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 9/28/2000 51 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2002 58 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 9/24/2004 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/3/2003 Female 12/17/2008 Consumer United States
Primary
Secondary
Injury Other Serious Female 1/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/1/1999 48 Female 130 lb 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/20/1998 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/13/1998 52 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/8/2000 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 7/23/2002 60 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/1999 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 9/20/2000 52 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/13/2003 Female 1/27/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/8/2002 50 Female 156 lb 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 43 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/22/2001 56 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2006 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2001 66 Female 145 lb 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2004 56 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/1999 48 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/13/2003 61 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/19/1997 42 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 4/16/2001 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 72 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/1999 51 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/28/2003 47 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1997 49 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2002 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/13/2003 Female 3/12/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/1996 Female 126 lb 3/23/2009 Lawyer United States
Primary
Secondary
Systemic Lupus Erythematosus Other Serious 2/26/2002 Female 106 lb 3/26/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/24/2002 Female 126 lb 3/31/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 Female 4/3/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/13/2003 Female 4/3/2009 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 3/2/2001 Female 220 lb 4/10/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 7/31/2003 Female 4/14/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/17/1999 Female 148 lb 4/16/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/19/2001 Female 4/24/2009 Lawyer United States
Primary
Secondary
Hot Flush Other Serious 1/1/2003 Female 161 lb 5/4/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/1/2000 Female 174 lb 5/5/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/12/2001 Female 5/7/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/1999 Female 5/15/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/28/2000 Female 181 lb 5/18/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/8/2000 Female 5/20/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/1/2006 Female 5/28/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 5/30/2002 Female 6/12/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/31/2001 Female 130 lb 6/16/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/1997 Female 6/30/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 7/8/2003 Female 7/24/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2002 Female 7/30/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2002 56 Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Male 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/1998 Female 9/17/2009 Lawyer United States
Primary
Secondary

Drug Data